Delivery Order SPE2DE22D0008-SPE2D625F7Q0U

Award Date 5/14/25
Potential Completion Date 5/19/25
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December...
This federal contract award, valued at $1,239.00, was made to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, awarded by the Defense Logistics Agency's Medical Supply Chain division, is for the delivery of ALBACYTE antibody screening cells, a critical product used in blood banking operations across various government agencies, including...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, is for the delivery of ALBACLONE Anti-A blood banking products with a ceiling value of $1,118.00. The contract is a Firm Fixed Price Delivery Order and has an ultimate...
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $17,441.00. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the supply of ALBACLONE Anti-P1 medical products, which are likely critical blood banking supplies supporting diagnostic testing, blood typing, and...
This federal contract award is a Blanket Purchase Agreement (BPA) from the U.S. Department of Veterans Affairs (VA) to Alba Bioscience, Inc. for blood bank products such as antibody identification panels, blood typing reagents, and quality control materials. The contract has a ceiling value of $12,020.06 and a term that runs through December 18, 2024. Alba Bioscience is a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics and blood banking supplies to...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, worth $1,740.00, is a delivery order under contract SPE2DE22D0008|SPE2D625F15SJ, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract is for the supply of ALBACYTE Antibody ID Panels, which are specialized 16-cell panels used for antibody identification in blood banking operations. This contract does...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The contract, valued at $1,304.00, is for the delivery of an ALBAHANCE LISS...
This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems. Alba Bioscience, a...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D625F7Q0U
    Delivery Order

This federal contract award was made by the Medical Supply Chain, a defense agency, to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The $1,560.00 firm fixed price delivery order is for ALBACLONE anti-LEA products, with a completion date of May 19, 2025.

Alba Bioscience, Inc. holds several significant federal Indefinite Delivery Vehicles (IDVs), including Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs (VA) for blood bank reagents and red blood cell reagents valued at $199,671.75 and $109,420.35 respectively. These IDVs, established under the GSA Schedule 65-VII, allow VA medical facilities to efficiently procure specialized blood banking supplies. The contract was awarded without a set-aside designation, indicating Alba Bioscience's competitive position in providing these critical medical diagnostic products to federal healthcare agencies.

Generated 8/17/25, 1:04 AM